Revvity Inc
RVTY94.685USD
-0.375-0.39%
收盤 04/29, 16:00（美東）報價延遲15分鐘
11.42B總市值
42.25本益比TTM
關於 Revvity Inc 公司
Revvity, Inc. 是一家健康科學解決方案、技術和服務提供商，提供從發現到開發、從診斷到治療的工作流程。其部門包括生命科學和診斷。生命科學部門提供面向生命科學市場的產品和服務。生命科學部門的應用包括 MicroBeta、MuviCyte 活細胞成像系統、Signals Image Artist、VICTOR Nivo 多模式平板讀取器臺式系統、EnSight 多模式平板讀取器臺式系統、BioLegend LEGENDplex 基於珠子的試劑和 Quantum GX2 系統。其診斷部門開發診斷、工具和應用程序，專注於生殖健康、免疫診斷和應用基因組學市場的臨牀導向客戶。它爲醫院和醫療實驗室提供儀器、試劑、檢測平臺和軟件。它專注於生殖健康、免疫診斷和新興市場診斷。
公司簡介
公司代碼RVTY
公司名稱Revvity Inc
上市日期Jul 06, 1965
成立日期1947
CEODr. Prahlad R. Singh, Ph.D.
員工數量11000
證券類型Ordinary Share
年結日Jul 06
公司地址77 4Th Avenue
城市WALTHAM
上市交易所NYSE Consolidated
國家United States of America
郵編02451
電話17816636900
網址https://www.revvity.com/
公司代碼RVTY
上市日期Jul 06, 1965
成立日期1947
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
42.60K
-0.26%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
23.60K
+3.43%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
11.29K
+7.45%
Mrs. Anita Gonzales
Mrs. Anita Gonzales
Vice President, Controller
Vice President, Controller
4.52K
+19.31%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
3.02K
-28.21%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
42.60K
-0.26%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
23.60K
+3.43%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
暫無數據
地區USD
名稱
營收
佔比
Americas
1.22B
44.39%
United States
1.10B
39.85%
Other Foreign
1.09B
39.72%
Asia
789.33M
28.65%
Europe
742.61M
26.95%
Other
-2.19B
-79.57%
業務
地區
暫無數據
股東統計
更新時間: 2月21日 週五
更新時間: 2月21日 週五
持股股東
股東類型
持股股東
股東統計
佔比
T. Rowe Price Investment Management, Inc.
17.28%
The Vanguard Group, Inc.
11.85%
T. Rowe Price Associates, Inc.
6.21%
Janus Henderson Investors
5.29%
BlackRock Institutional Trust Company, N.A.
5.00%
Other
54.37%
持股股東
股東統計
佔比
T. Rowe Price Investment Management, Inc.
17.28%
The Vanguard Group, Inc.
11.85%
T. Rowe Price Associates, Inc.
6.21%
Janus Henderson Investors
5.29%
BlackRock Institutional Trust Company, N.A.
5.00%
Other
54.37%
股東類型
股東統計
佔比
Investment Advisor
52.38%
Investment Advisor/Hedge Fund
34.65%
Hedge Fund
2.53%
Bank and Trust
1.60%
Pension Fund
1.55%
Research Firm
1.34%
Sovereign Wealth Fund
1.02%
Individual Investor
0.29%
Family Office
0.05%
Other
4.58%
機構持股
更新時間: 1月20日 週一
更新時間: 1月20日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
1212
114.89M
95.62%
-2.87M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
2023Q1
1406
108.31M
85.69%
-5.19M
2022Q4
1441
108.60M
86.00%
-7.85M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
T. Rowe Price Investment Management, Inc.
20.76M
17.28%
+2.97M
+16.69%
Dec 31, 2024
The Vanguard Group, Inc.
14.24M
11.85%
+157.96K
+1.12%
Dec 31, 2024
T. Rowe Price Associates, Inc.
7.46M
6.21%
+1.15M
+18.27%
Dec 31, 2024
Janus Henderson Investors
6.36M
5.29%
+23.65K
+0.37%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
6.01M
5%
-158.82K
-2.58%
Dec 31, 2024
State Street Global Advisors (US)
5.17M
4.3%
-13.79K
-0.27%
Dec 31, 2024
EdgePoint Investment Group Inc.
4.06M
3.38%
+1.37M
+51.10%
Dec 31, 2024
Mitsubishi UFJ Asset Management Co., Ltd.
3.38M
2.82%
+69.03K
+2.08%
Dec 31, 2024
Capital Research Global Investors
2.99M
2.49%
-97.75K
-3.17%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.90M
2.41%
+37.67K
+1.32%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
Otter Creek Focus Strategy ETF
2.72%
T Rowe Price Capital Appreciation Equity ETF
2.21%
Franklin Genomic Advancements ETF
1.87%
Invesco S&P 500 Equal Weight Health Care ETF
1.52%
Simplify Health Care ETF
1.28%
VanEck Morningstar SMID Moat ETF
1.25%
First Trust Indxx Medical Devices ETF
1.24%
Janus Henderson US Sustainable Equity ETF
1.11%
First Trust Health Care Alphadex Fund
0.87%
ROBO Global Healthcare Technology & Innovation ETF
0.86%
查看更多
Otter Creek Focus Strategy ETF
佔比2.72%
T Rowe Price Capital Appreciation Equity ETF
佔比2.21%
Franklin Genomic Advancements ETF
佔比1.87%
Invesco S&P 500 Equal Weight Health Care ETF
佔比1.52%
Simplify Health Care ETF
佔比1.28%
VanEck Morningstar SMID Moat ETF
佔比1.25%
First Trust Indxx Medical Devices ETF
佔比1.24%
Janus Henderson US Sustainable Equity ETF
佔比1.11%
First Trust Health Care Alphadex Fund
佔比0.87%
ROBO Global Healthcare Technology & Innovation ETF
佔比0.86%
分紅派息
近5年累計派現
168.35M
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
Apr 25, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 11, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 11, 2023
Jul 20, 2023
Jan 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 12, 2023 going ex on Apr 20, 2023
Apr 21, 2023
May 12, 2023
Apr 20, 2023
Oct 27, 2022
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 10, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Feb 10, 2023
Jan 19, 2023
Jul 22, 2022
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 11, 2022 going ex on Oct 20, 2022
Oct 21, 2022
Nov 11, 2022
Oct 20, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據